Načítá se...
Physiologic Doses of Ascorbic Acid Increase Arsenic Trioxide Toxicity in Human Jurkat -T Lymphoma Cells
BACKGROUND: Arsenic trioxide (ATO) has been reported to have activity in vitro against multiple myeloma cells. Recently, it has also been used as a therapeutic agent to treat acute promyelocytic leukemia (APL) patients who have relapsed from conventional treatment with all-trans retinoic acid (ATRA)...
Uloženo v:
| Vydáno v: | Met Ions Biol Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577053/ https://ncbi.nlm.nih.gov/pubmed/26401102 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|